The first definitive haematopoietic stem cells (dHSCs) in the mouse emerge in the dorsal aorta of the embryonic day (E)10.5-11 aorta-gonad-mesonephros (AGM) region. Notch signalling is essential for early HSC development but is dispensable for the maintenance of adult bone marrow
) which are mainly present at E11.5 (24) (25) (26) (27) (28) (29) . In contrast to dHSCs, these precursors are not detectable by direct transplantations into adult irradiated recipients. A maturation step in an embryonic or neonatal environment is needed to allow them to develop into transplantable dHSCs (24) (25) (26) (27) .
The Notch pathway is involved in numerous biological processes such as cell fate decisions, stem cell homeostasis, proliferation and apoptosis (30, 31) . Interactions of Notch receptors with ligands (in mammals, Notch1-4 and Jag1-2, Dll1, 4, respectively) release the Notch intracellular domain, which, through collaboration with the RBP-Jtranscription factor, activates Notch targets such as transcriptional repressor Hes1 (32) . Notch plays an important role in embryonic HSC development (33) (34) (35) but is dispensable for adult bone marrow HSCs (36, 37) . Notch1 mutant ES cells fail to contribute to adult haematopoiesis, suggesting its cell-autonomous role in HSC specification (38) . Notch signalling is required for specification of the haematogenic endothelium in the lateral plate mesoderm (39) (40) (41) and for establishing arterial identity of the endothelium, closely related to the haematopoietic specification (33, (42) (43) (44) (45) (46) . Mouse Notch1, Jag1 or RBP-J mutants are embryonic lethal and exhibit severely impaired haematopoiesis concurrent with expansion of the aortic endothelial cell population, suggesting regulation of the haematogenic endothelium fate by Notch1-Jag1 signalling (33) (34) (35) . Notch2 knockouts show no obvious haematopoietic defects (33) and Notch3 and Notch4 knockouts are viable, indicating their non-essential role in HSC development (43, 47) . The requirement for Notch in the endothelial-haematopoietic transition is conserved in zebrafish (19, (48) (49) (50) (51) , where Notch1 acts through activation of and co-operation with important transcription factors such as Gata2, Runx1, Scl, Foxc2 and Hes1/5 (34, 48, (50) (51) (52) (53) (54) . Although Notch is essential for early HSC development, exact stage-specific requirements for this signalling pathway in this multi-step maturation process remain unclear.
Here we show that although Notch signalling is active in and critical for pre-HSC development, down-regulation of Notch activity during transition from the pre-HSC Type I to the Type II stage is essential for this process. However, Notch signalling is largely dispensable for the next step of maturation of pre-HSCs Type II into dHSCs in the AGM region. Although Notch1 is the dominant Notch receptor player, Notch2 also contributes to pre-HSC development. Thus, consistently with the acquisition of the adult status, developing HSCs in the AGM region gain Notch independency, which is a hallmark of adult bone marrow HSCs (36) .
Materials and Methods

Mice
Wild type and transgenic mouse lines (all C57BL/6, CD45.2/2) used were: 1) a pHes1-d2EGFP 
Cultures
Reaggregates and explants were cultured at the liquid-gas interface. Pre-HSC populations sorted from one AGM region were co-aggregated with 10 5 OP9 cells and cultured on filter for 5 days in presence of cytokines (IL-3+SCF+Flt3 ligand; PeproTech) as previously described (25, 26) . After culture, single-cell suspensions prepared by dispase/collagenase digestion were used for CFU-C and transplantation assays and FACS analysis (26) .
Cre-mediated recombination of RBP-J For blocking Notch, freshly isolated AGM cell suspensions were incubated before culture with DAPT (Calbiochem), or Notch1 and Notch2 blocking antibodies (anti-NRR1 and anti-NRR2, Genentech) for at least 20mn at 37 o C. DAPT (50M) or blocking antibodies (10g/ml) were also added to the medium at the beginning of the culture.
Transplantations
Embryonic single-cell suspensions (CD45.2/2) were injected into adult recipients (CD45.1/2) along with 20,000 CD45.1/1 bone marrow carrier cells. Recipients were irradiated by split dose (600 + 550 rad with 3h interval) of γ-irradiation. The cell numbers of a particular population are expressed in doses, defined as embryo equivalent (ee), which corresponds to the number of given cells in one AGM region (for example, 0.2ee is equal to 20% of a given cell population in one AGM region). Donorderived chimerism was monitored in blood at 6 and 14 weeks after transplantation by FACS.
Peripheral blood cells treated with PharmLyse were stained with anti-CD16/32, anti-CD45.1-APC (clone A20), and anti-CD45.2-PE (clone 104) antibodies (eBioscience). Different groups of repopulated mice were compared using Mann-Whitney statistical tests.
Flow cytometry
Flow cytometry was performed using FACS Calibur and Fortessa (analysis) and FACS Aria II or FACS Aria Fusion, using FACS Diva software (sorting). Data were analyzed in FlowJo software (TreeStar). The antibodies used are listed in Table S1 . Cell viability was assessed using 7-aminoactinomycin D (7-AAD) or ethidium monoazide (EMA). Gates were set using fluorescence minus one 
Dll1 doxycycline inducible OP9 cell line (OP9-Dll1)
Delta-like1 (Dll1) cDNA was cloned into a doxycycline inducible bicistronic expression vector pPBhCMV1-cHA-IRESVenuspA (gift from H. Niwa (58) ) that allowed both Dll1 and Venus to be expressed upon induction. 100,000 OP9 cells were electroporated with this construct using NEON transfecting system (Invitrogen). The next day the electroporated cells were cultured in the presence of Table S2 .
qRT-PCR
Results
Notch signals in pre-HSCs and dHSCs
To analyze Notch signalling in the developing HSC lineage, we first examined expression of Table S3 ). We then investigated whether functional pre-HSCs express Notch1 and Notch2 by using the OP9 co-culture system, which allows pre-HSCs to mature into detectable HSCs (24, 25) . Functional analysis using sorted Notch1 positive and Notch1 negative cells from E11.5 AGM region followed by co-aggregation with OP9 cells and transplantation into irradiated recipients confirmed that Notch1 is expressed in all pre-HSCs (both Type I and Type II), since only Notch1 + cells were able to generate dHSCs ( Figure 1C ). Similar functional tests showed that some pre-HSCs Type II also express Notch2 ( Figure 1D , Figure S1A The analysis of mature dHSCs sorted from freshly isolated AGM regions one day later at E12.5 showed that they also reside both in the GFP -and GFP + fractions ( Figure 2C , Figure S4A ). The foetal liver HSC population, which consists of mature dHSCs (29) and is defined by SLAM markers(60), was phenotypically predominantly Hes1-GFP+ ( Figure 2D ) as shown previously (61) .
However, functional transplantations showed that true dHSCs in E12.5-E14.5 foetal livers reside only in Hes1-GFP neg and Hes1-GFP low fractions, with a tendency towards negative fractions ( Figure 2E , Figure S4B and unpublished data). Thus, although Notch signalling is active in all pre-HSCs at E10.5, it is down-regulated in the HSC lineage during further development.
Attenuation of Notch dependency during pre-HSC maturation
Expression analysis of Notch receptors and Hes1-GFP suggested that Notch signalling is functionally involved in pre-HSC maturation. To test this, we first blocked Notch activity by adding DAPT/-secretase inhibitor to AGM explant cultures and assayed the outcome of dHSCs by the long-term repopulation assay ( Figure 3A ). While addition of DAPT to E10.5 AGM explant cultures almost fully blocked HSC development, the production of dHSCs by E11.5 explants was less affected as most of recipients were repopulated, albeit at significantly lower levels compared to untreated controls ( Figure   3A ). Accordingly, maturation of purified pre-HSCs Type II from E11.5 embryos was only partially affected by DAPT ( Figure 3B ). Altogether these data suggest that while most pre-HSCs are sensitive
to Notch blockade at E10.5, at later stages they do not require Notch for maturation into dHSC.
Meanwhile, in keeping with previous reports(33), production of myeloid progenitors (CFU-C) from E10.5 AGM culture was not significantly affected by DAPT treatment ( Figure 3C ).
Since DAPT can affect other molecular pathways mediated by -secretase, we genetically Since this result is in apparent discrepancy with DAPT treatment experiments at E10.5 ( Figure   3A ), we analyzed the clearance of RBP-J protein and found its presence at high levels 24h after induction of genetic ablation ( Figure 3G ). Only 36h after induction of deletion did RBP-J protein completely disappears (data not shown). We reasoned that the persistence of RBP-J protein during the first day of culture may ensure support of HSC development until the stage at which they become independent of Notch signalling. We tested this hypothesis by adding DAPT with a 24-hours delay and found that in this case the production of dHSCs by pre-HSCs type II indeed, was not affected (compare Figure 3B and 3D). Thus, pre-HSCs become Notch independent shortly before becoming mature dHSCs. Notably, the kinetics of loss of Notch signalling corroborates this conclusion: indeed after 24 hours in culture, pre-HSCs Type II, which initially express Hes1-GFP ( Thus, although at E10.5 pre-HSC development depends on active Notch signalling based on the DAPT treatment experiments ( Figure 3A) , by E11.5 at least some pre-HSCs down-regulate it ( Figure 2B ) and their maturation into dHSCs no longer requires Notch ( Figure 3A , B, D, E).
Down-regulation of Notch signalling is required for the pre-HSC Type I to Type II transition
Although Notch signalling is down-regulated during HSC maturation and eventually becomes dispensable, it is not clear whether this down-regulation is a necessary step for their development. To test this, we co-aggregated Hes1-GFP + pre-HSCs with Dox-inducible OP9-Dll1 in order to maintain Notch signalling during HSC maturation. In these experiments, we enriched pre-HSCs using positive CD43, cKit, Sca1 and lin-negative markers(24) (data not shown).
Upon doxycycline induction, Dll1 was upregulated in the inducible OP9 cell line ( Figure   S3A ) and, accordingly, Hes1-GFP expression in pre-HSCs was maintained in culture, in contrast to control conditions with un-manipulated OP9 ( Figure 4A -B). We found that such an enforced Notch activity significantly impaired maturation of pre-HSCs Type I but not pre-HSCs Type II ( Figure 4C ), suggesting that Notch down-regulation is critically important for pre-HSC Type I to Type II transition but not thereafter.
Both Notch1 and Notch2 activity are involved in pre-HSC maturation
We have shown that both Notch1 and Notch2 are expressed in pre-HSCs (Figure 1 ). We therefore tested whether Notch1 and Notch2 are functionally involved in pre-HSC development using highly specific blocking antibodies, anti-NRR1 and anti-NRR2, respectively (63) . Treatment with each antibody led to down-regulation of Notch target genes, comparable to DAPT treatment ( Figure S7A -B). Since Notch1, but not Notch2, is involved in arterial specification (64), treatment with anti-NRR1
but not anti-NRR2 down-regulated Notch1 itself and CD44, both known as arterial markers (65) ( Figure S7C ). As expected, in contrast to Notch1-mediated regulation of itself, anti-NRR2 did not reduce Notch2 protein levels ( Figure S7D ).
In functional experiments, E10.5 AGM (containing predominantly pre-HSCs type I), or E11.5 sorted pre-HSCs enriched for pre-HSC Type II, were cultured in presence of either anti-NRR1 or anti-NRR2 antibodies. Blocking of either Notch1 or Notch2 drastically suppressed HSC development in the E10.5 AGM region in agreement with DAPT treatment (compare Figure 3A and 5A). Similarly, at E11.5, maturation of sorted pre-HSC Type II was inhibited by addition of blocking antibodies, but to a lesser extent than at E10.5, in agreement with DAPT treatment (compare Figure 3B and 5B). Notably, blocking with anti-NRR2 tended to be more effective than blocking with anti-NRR1, which correlates with an increase of Notch2 and decrease of Notch1 expression in pre-HSCs Type II ( Figure 1B ). As with DAPT treatment or after RBP-J deletion, the development of CFU-Cs was not disrupted ( Figure   5C ). Thus, in addition to the previously reported role of Notch1, Notch2 also plays a role in HSC development.
Discussion
Various molecular pathways are involved in early HSC development (66) . Notch signalling is critically important for early development of the haematopoietic system (67) . Mutants for the main components of Notch pathway lack haematopoietic progenitors and HSCs and showed an excess of endothelial cells (33) (34) (35) 68) . Several lines of evidence suggest that Notch controls the development of intra-embryonic haematopoiesis by regulating essential transcription factors which are involved in the endothelial-to-haematopoeitic transition (34, 50) . However, HSC development occurs through several sequential maturation steps, which involve a hierarchy of precursors (pre-HSCs) fully committed to Although a Notch-mediated mechanism was proposed, it required TGF inhibition and might be explained by other than Notch-mediated mechanisms, as discussed by the authors themselves(87).
In conclusion, the HSC lineage during development in the AGM region switches from a Notch-dependent to a Notch-independent stage ( Figure 6 ). Our results reveal a temporal window of strong Notch dependency during the pre-HSC Type I to pre-HSC Type II transition in the E10.5-E11.5
AGM region ( Figure 6 ). Once pre-HSCs pass this stage, they become significantly less dependent on Notch, which is consistent with Notch independence in adult bone marrow HSCs (36, 88 antibody (clone 22E5.5; rat IgG2a) and R. Kageyama gave us the transgenic Hes1-GFP mice.
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